Jul 8, 2022

07/08/2022 | 02:14am EDT Message : July 2022 Mission What was once thought to be impossible is now a reality; we have become the only company in the world to successfully mass produce Quantum Dot LASERs. Our laser technology will enable dramatic improvements in our ability to process information. support visually impaired people, prevent eye diseases, and enhance vision, continually pushing the boundaries of human possibility. 1 Company Name Location Laser Eyewear Division 24, Corporate and others: 12) Business of semiconductor laser and its application products Licenses • Registration of medical equipment manufacturer • ISO 9001 Company History Listed on the TSE Mothers market in February 2021 (Securities code: 6613) Medical device shipment started in March 2021 Medical device "RETISSAⓇ Medical" shipment started. History Spun-off from Fujitsu and signed joint research agreement with The University of Tokyo Approval to market World's first mass production of "RETISSA® Display" for consumer use quantum dot lasers for optical communication 2006 Award at the Green IT Awards 2010 President & CEO Mitsuru Sugawara won the Japan Prime Minister Award Major Awards 9th Medtec Innovation Award International award given for outstanding innovations in the optics field 3 Semiconductor Laser Devices Solid earnings base and high growth potential due to expansion of global laser market ⇒Record high sales forecast for this term. Steady and further growth expected in every product. ⇒The silicon photonics market is emerging, with mass production shipment of quantum-dot lasers approaching. 3 Laser Retinal Projection Technology Commercialization of eyewear utilizing the world's first retinal projection technology ⇒Sales of laser eyewear for consumer and medical equipment increased, and the development of next-generation laser eyewear Retissa Display 3 progressed. Launch of three new products that apply retinal projection technology. Trial operation of "vision health screening" business. 4 ESG initiatives